GPI 250 mg 907 (Penicillamine 250 mg)
Pill with imprint GPI 250 mg 907 is White, Capsule-shape and has been identified as Penicillamine 250 mg. It is supplied by Granules Pharmaceuticals Inc.
Penicillamine is used in the treatment of wilson's disease; rheumatoid arthritis; cystinuria and belongs to the drug class antirheumatics. There is positive evidence of human fetal risk during pregnancy. Penicillamine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GPI 250 mg 907
Penicillamine
- Imprint
- GPI 250 mg 907
- Strength
- 250 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antirheumatics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Granules Pharmaceuticals Inc.
- National Drug Code (NDC)
- 70010-0907
More about penicillamine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (2)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: antirheumatics
Patient resources
- Other brands
- Cuprimine, Depen, D-Penamine, Depen Titratabs
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.